Unknown

Dataset Information

0

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.

ABSTRACT:

SUBMITTER: Launay O 

PROVIDER: S-EPMC9258749 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Transcriptomics Safety and immunogenicity of the recombinant BCG vaccine VPM1002, in South African infants
2017-01-09 | GSE86627 | GEO
Unknown Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.
| S-EPMC2602972 | biostudies-literature
Unknown Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine.
| S-EPMC3957681 | biostudies-literature
Unknown Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.
| S-EPMC7686206 | biostudies-literature
Unknown Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer.
| S-EPMC8700280 | biostudies-literature
Unknown Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.
| S-EPMC6766894 | biostudies-literature
Unknown Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.
| S-EPMC6938982 | biostudies-literature
Unknown Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study.
| S-EPMC7556121 | biostudies-literature
Unknown Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects.
| S-EPMC2291031 | biostudies-literature
Unknown Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.
| S-EPMC2923449 | biostudies-literature